ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 32

T Cell-Intrinsic Nod2 Protects Against Th17-Mediated Autoimmune Arthritis in SKG Mice

Ruth Napier1, Ellen Lee1, Emily Vance1, Paige Snow2, Clare Dawson3, Kimberly Samson4, Amy Moran5, Michael Davey6, Shimon Sakaguchi7 and Holly Rosenzweig1, 1Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, 2Molecular Microbiology and Immunology, VA Portland Health Care System, Portland, OR, 3Portland VA, PORTLAND, OR, 4Oregon Health & Science University, Portland, OR, 5Cell, Developmental, and Cancer Biology, Oregon Health & Science University, Portland, OR, 6VA Portland Health Care System, Portland, OR, 7Osaka University, Osaka, Japan

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Arthritis, Mouse model, nod-like receptor (NLR) and rheumatoid arthritis (RA), T cells

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, October 21, 2018

Title: Rheumatoid Arthritis – Animal Models Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Nucleotide-binding oligomerization domain-containing protein 2 (Nod2) is an innate immune receptor known primarily for its role in host protection against bacterial infections. Intriguingly, Nod2 also appears to have a role outside of infection, as a single point mutation in this molecule leads to 100% incidence of arthritis in Blau Syndrome. Although the contribution of autoreactive CD4+ T cells to autoimmune arthritis is appreciated, the molecules that regulate their development and propagation remain unknown. Here we sought to elucidate the role of Nod2 in the generation of autoreactive CD4+ T cells using SKG mice, which are genetically predisposed to arthritis.

Methods: SKG and Nod2-/-SKG mice housed under specific pathogen-free conditions were i.p. injected with zymosan (1.5 mg) at 6-8 wk age, clinically monitored for arthritis and analyzed histologically for joint pathology. CD4+ T cells from ankle-draining lymph nodes of na•ve or zymosan treated mice were stimulated in vitro with PMA/io and production of pro-inflammatory cytokines was quantified by ICS and flow cytometry. IL-17 concentration in synovial fluid was determined by ELISA. The role of IL-17 in disease was assessed by in vivo neutralization with anti-IL-17A monoclonal antibody. T regulatory (Treg) cell (CD4+CD25+Foxp3+) frequency and ability to suppress T effector (CD4+CD25–) cell proliferation was determined by Treg suppression assays and flow cytometry. For adoptive T cell transfers, splenic CD4+ T cells (4×106) purified from na•ve mice by magnetic positive selection were injected i.v. into lymphopenic Nude (nu/nu) recipients who were injected 24h later with zymosan. Experiments were performed three independent times (n=5-6 mice/genotype) and data were analyzed using non-parametric statistics.

Results: Nod2-/- SKG mice developed markedly worse arthritis following zymosan injection that coincided with increased numbers of pro-inflammatory Th17 (CD4+IL-17+) cells in the ankle-draining lymph nodes and elevated IL-17 protein levels in joint synovial fluid. The increase in Th17 cell frequency was likely not due to compromised Treg responses as the frequency and suppressive capacity of Tregs was not affected by Nod2 deletion. Neutralization of IL-17A in vivo attenuated arthritis in Nod2-/- SKG mice suggesting Nod2 is a negative regulator of IL-17. Importantly, CD4+ T cells from na•ve Nod2-/-SKG mice had a fundamental capacity to produce more IL-17 and had enhanced ability to passively transfer arthritis to T cell-deplete nude recipients.

Conclusion: These data uncover a previously unappreciated role for T cell-intrinsic Nod2 as an endogenous negative regulator of the Th17 response and the arthritogenicity of CD4+ T cells on a single cell level. Understanding how Nod2 participates in immune tolerance mechanisms could illuminate protective mechanisms in arthritis that may be exploited for the future development of novel treatments.


Disclosure: R. Napier, None; E. Lee, None; E. Vance, None; P. Snow, None; C. Dawson, None; K. Samson, None; A. Moran, None; M. Davey, None; S. Sakaguchi, None; H. Rosenzweig, None.

To cite this abstract in AMA style:

Napier R, Lee E, Vance E, Snow P, Dawson C, Samson K, Moran A, Davey M, Sakaguchi S, Rosenzweig H. T Cell-Intrinsic Nod2 Protects Against Th17-Mediated Autoimmune Arthritis in SKG Mice [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/t-cell-intrinsic-nod2-protects-against-th17-mediated-autoimmune-arthritis-in-skg-mice/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/t-cell-intrinsic-nod2-protects-against-th17-mediated-autoimmune-arthritis-in-skg-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology